Thomas W. Dubensky

Insider Reports History

Entity
Individual
Location
C/O Aduro Biotech, Inc., 740 Heinz Avenue, Berkeley, CA
Signature
/s/ Stephen Brady, Attorney-in-Fact for Thomas W. Dubensky
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas W. Dubensky:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. President, Director Employee Stock Option (right to buy) 103K Jan 3, 2023 Direct
HTG MOLECULAR DIAGNOSTICS, INC Director Stock Option (right to buy) 8K Aug 18, 2022 Direct

Insider Reports Filed by Thomas W. Dubensky

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TPST Tempest Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 President, Director
HTGMQ HTG MOLECULAR DIAGNOSTICS, INC Aug 18, 2022 1 $0 4 Aug 22, 2022 Director
HTGMQ HTG MOLECULAR DIAGNOSTICS, INC Aug 18, 2022 0 $0 3 Aug 19, 2022 Director
TPST Tempest Therapeutics, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 President, Director
TPST Tempest Therapeutics, Inc. Jan 7, 2022 1 $9.56K 4 Jan 11, 2022 President, Director
TPST Tempest Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 6, 2022 President, Director
TPST Millendo Therapeutics, Inc. Jun 25, 2021 5 $0 4 Jun 29, 2021 President, Director
TPST Millendo Therapeutics, Inc. Jun 25, 2021 0 $0 3 Jun 29, 2021 President, Director